MEDICHEM STRENGTHENS ITS COMMITMENT TO SUSTAINABILITY AND TRANSPARENCY: EINF REPORT
04/12/2023
Medichem once again takes a significant step towards transparency and accountability by presenting its Non-Financial Report (EINF), highlighting a strong commitment to sustainable and ethical business practices. Over the years, the company has implemented various initiatives to reduce its environmental impact and contribute to the well-being of the communities it serves.
This report not only demonstrates dedication to transparency but also underscores the integrity and sustainability ingrained in Medichem’s corporate management. We share our progress with stakeholders, including teams, suppliers, customers, and communities, on our journey towards a more responsible future.
While celebrating these achievements, we acknowledge the pending challenges and the need to persevere in our efforts to achieve a positive and sustainable impact on our environment and society. Our commitment to transparency permeates every aspect of our operations, and this report provides a comprehensive view of our practices in key areas such as environmental initiatives, social impact, human rights, and sustainable development.
Looking ahead, we are excited to tackle new challenges and elevate our standards to contribute to a more sustainable and responsible future. At Medichem, we understand that the path to excellence in the industry is continuous, and we are committed to advancing towards a better and more sustainable tomorrow.
MEDICHEM: INTEGRATING SOCIAL, ENVIRONMENTAL, HUMAN RIGHTS, AND SUSTAINABLE DEVELOPMENT COMMITMENTS ACROSS ALL DIMENSIONS OF OUR OPERATIONS
In its second Sustainability Report, Medichem aligns with Act 11/2018, emphasizing enhanced measurement and content. Acknowledging pharmaceutical industry demands, compliance is integrated into decision-making. In 2022, recognized as one of Spain’s fastest-growing companies by CEPYME500, Medichem excelled in economic, R&D, digitalization, and ESG aspects. Key achievements include efficiency improvements, launching the first generic cardiovascular blockbuster in Europe, and initiating the “Caring for the Future” ESG project with a dedicated team and external consultancy support. The company underscores its commitment to sustainability through an Action Plan guiding decision-making for enhanced environmental and social impact.
MEET OUR OPERATIONAL COMMITMENTS ACROSS DIMENSIONS:
Human Capital: Medichem prioritizes people, implementing over 200 actions for talent identification, retention, and comprehensive training. Human Resources played a pivotal role in successfully implementing Hanna 4/SAP in Spain, facilitating over 150 “Change Management” actions.
Natural Capital: Under the “Caring for the Future” initiative, Medichem focuses on environmental sustainability, renewing ISO 14001:2015 certification, practicing solvent reuse, and investing in low-impact renewable energy, exemplified by solar panels at the Celrà plant.
Government: Medichem adopts a Compliance System, extending comprehensive training to Maltese subsidiaries. Monthly monitoring of R&D investment results in successful licensing to American partners. The “TOB: Thinking Out of the Box” initiative fosters innovation.
Manufacturing Capital: The Ecovadis project launch emphasizes transparency and reduced environmental impact with 57 key suppliers. Medichem’s project to identify European suppliers aims to cut the CO2 footprint and strengthen the value chain, aligned with the “Caring for the Future” initiative’s clear objectives reflecting commitment to sustainability
